PORTABLE HOME DEVICE FOR EARLY DETECTION OF BREAST CANCER
(NewsUSA)
- The ScanEase OneSense device is a screening tool for diagnosing breast cancer. The device facilitates an examination that is accessible to patients of any age and body type, allowing for self-examination due to its user-friendly design in the privacy of their home. The results help assess the risk of new tissue formations in the breast. The higher the risk factor on the BI-RADS scale, the greater the likelihood of malignant tissue degeneration. In light of this, the OneSense scanning device is recommended for the primary diagnosis of breast tumors in outpatient settings and for at-home self-examinations. The scan results are visible through an app on your smartphone, which will advise whether you should consult with a physician.
Measurement method:
The device measures the distribution of conductivity between the electrodes on the surface of the breast, which is influenced by the distribution of blood flow in the breast tissue. The device utilizes the well-known principle of bioimpedance, measuring the difference in electrical conductivity between healthy and cancerous tissues, as tumor growth significantly increases blood flow. This allows the device to demonstrate a high specificity in breast cancer diagnostics. The results obtained from using the device will enable physicians to enhance the diagnostic quality of fibroepithelial and non-epithelial breast formations, as diagnostic errors occur in 20% to 60% of cases during routine patient examinations. The widespread use of ScanEase scanning technology will reduce the reliance on X-ray mammography and MRI examinations as routine methods for assessing breast health, thereby decreasing radiation exposure.
A unique software with a proprietary AI-based algorithm has been developed, enabling users to determine the risk factor for the presence of neoplasms in breast tissue immediately after screening, with an accuracy of up to 85%. The bioimpedance method identifies areas of increased electrical conductivity in a woman's mammary gland, that are formed due to increased blood flow, which is characteristic of tumor development.
The interpretation of the obtained data is performed by an AI-based system using the international BI-RADS scale, which indicates a complex 'risk factor' parameter on a specialized point scale. This approach standardizes and digitizes the data description using original algorithms, allowing for an assessment of the patient's risk according to the BI-RADS scale. The method makes it possible to reliably divide patients into 3 groups of threats based on the magnitude of the risk factor: low, medium and high risk.
The user of the scanning device can immediately view the results through an app on their smartphone. If a medium or high-risk result is indicated, the person should promptly contact their physician for further diagnosis.
In early 2025, the device will enter FDA clinical trials on a fast-track basis for a non-invasive medical trial. Upon final FDA approval, the device will be available for purchase online, with a projected cost of $350. The device can be shared among friends and family, reducing the cost per person using it. View the Company’s website at www.scanease.co or send an email to [email protected] to request more detailed information.
- Life is uncertain, and there is no time like the present to be sure that you have life insurance in place. A life insurance plan provides affordable and lasting financial protection for you and your loved ones, and it does not have to be expensive.
- After Mining, Crafting, and Battling Through the In-Person, Immersive Minecraft Adventure, Each Guest Receives a Limited-Edition Half-Zombie, Half-Villager Cape World Premiere Set For Dallas October 18; Tickets On Sale Now
- Choosing The Right Marketing Agency,
- The United States leads the world in artificial intelligence (AI), but this edge is at risk without a solution to the energy crisis caused by data centers that power AI, onshore manufacturing, and rapid electrification
- Over the years, service dogs have become an increasingly familiar sight on trains, planes and buses; in restaurants, nail salons and shopping malls, and even at the beach, diligently escorting and protecting their human charges through blindness, hearing loss, ambulatory limitations and even mental-health challenges—there are now half a million service dogs at work in this country. I’ve come to marvel at these fantastic beasts, the organizations and volunteers who train them and the Americans with Disabilities Act that provides a protective infrastructure. These four-legged friends are heroes. Heroes, one and all.
Over time, Baby mellowed and began to display affection for me. Perhaps that’s because she realized I was the sole provider of her food and walks, but I like to think it was more than that. We became inseparable, velcroed together. On the rare occasion that I left our house, Baby welcomed me home as if I was returning from the war. She started to sleep on the pillow next to mine, and the moment my eyes opened, I was the recipient of a thorough tongue bath.
-
When it comes to installing a pool, spring and summer are the seasons that logically come to mind. But the best time to add a pool to your backyard is actually in the fall. There are definite advantages to installing later in the year that can make the process smoother, more cost-effective and, ultimately, more enjoyable.
- As we age, maintaining physical fitness and the ability to move our body easily becomes more important to our overall well-being. However, an often-overlooked condition known as sarcopenia can gradually lower individuals’ muscle mass and strength without obvious warning.
- Si eres uno de los
-
You Are More Than: A Primer for Finding the Light in Your Heart by Amy L. Stark, Ph.D.
Marvelous Jackson by Laura Anne Bird
Recalibrating Gravity by Mary Keating
Between Islands by Robert Coburn